Logo do repositório
 
Publicação

Antioxidant and neuroprotective potential of mushroom biomass: effects on ROS production in human microglial cell line (HMC3) and alzheimer’s disease caenorhabditis elegans models

2025-12-05Documento de conferência Acesso aberto
Ver registo simples
dc.contributor.authorAraújo-Rodrigues, Helena
dc.contributor.authorGarzón-García, Lidia
dc.contributor.authorSalsinha, Ana Sofia
dc.contributor.authorRelvas, João B.
dc.contributor.authorTavaria, Freni Kekhasharú
dc.contributor.authorSantos-Buelga, Celestino
dc.contributor.authorGonzález-Paramás, Ana M.
dc.contributor.authorPintado, Manuela E.
dc.date.accessioned2026-01-23T09:13:12Z
dc.date.available2026-01-23T09:13:12Z
dc.date.issued2025-12-05
dc.description.abstractBackground: Mushrooms exhibit diverse bioactive compounds with prebiotic, immunomodulatory, antioxidant, and neuroprotective effects. These benefits may arise from direct metabolite absorption and gut microbiota modulation, a key regulator of brain health through the gut-brain axis1. This study explored the neuroprotective potential of macromolecules from the mushroom biomass (MB) from Trametes versicolor (TV), Hericium erinaceus (HE), and Pleurotus ostreatus (PO) before and after gastrointestinal digestion (GID), together with microbiota-derived metabolites. Their effects were evaluated in the human microglial cells (HMC3) by ROS measurement and in transgenic Caenorhabditis elegans Alzheimer’s disease (AD) models by chemotaxis and paralysis assays. Methods: Bioactive compounds in MBs were quantified by enzymatic assays, HPLC, and spectrophotometric methods. GID was simulated by the INFOGEST standardized method, and the microbiota-derived metabolites were determined by human fecal fermentation. Intracellular ROS in HMC3 cells were measured using a fluorescent probe. Transgenic C. elegans AD models were used for chemotaxis and paralysis assays. Results: Biochemical characterization of MBs confirmed the presence of bioactive compounds with antioxidant potential. TV showed higher levels of ?-aminobutyric acid (GABA; 125.99 mg/100 g), ergosterol (8.97 mg/100 g), ascorbic acid (3.31 mg/100 g), carotenoids (18.05 mg/100 g), and free phenolic compounds (113.31 mg GAE/100 g). HE possessed higher tocopherol levels (816.74 ?g/100 g), while PO was richer in zinc content (2.37 mg/100 g). Total glucan content (76.15-80.45%) and selenium content (87.68–93.04 ?g/100 g) were similar across species. All biomass species inhibited ROS production in microglia (15.35–21.29%) at 0.63–1.25 mg/mL. Digestive fractions of all mushroom species significantly improved chemosensory responses in the BR5270 strain, which expresses the hyperphosphorylated tau protein in neurons. TV, HE, and PO also significantly delayed paralysis progression in the CL4176 strain. Moreover, butyric acid and GABA restored chemotaxis deficits in CL2355 and delayed progressive paralysis in CL4176, both strains with amyloid beta peptide expression, indicating protective effects against amyloid-induced neuronal dysfunction. Conclusions: Mushroom biomass-derived compounds and microbiota metabolites show neuroprotective potential, mitigating A?- and Tau-induced toxicity, two of the main hallmarks of AD.eng
dc.identifier.citationAraújo-Rodrigues, H., Garzón-García, L., Salsinha, A. S., & Relvas, J. B. et al. (2025). Antioxidant and neuroprotective potential of mushroom biomass: effects on ROS production in human microglial cell line (HMC3) and alzheimer’s disease caenorhabditis elegans models. 1-1. Abstract from Microbiotec’25, Ponta Delgada, Portugal.
dc.identifier.other1d579ca7-ce40-40a0-98d2-cf3774628be1
dc.identifier.urihttp://hdl.handle.net/10400.14/56652
dc.language.isoeng
dc.peerreviewedyes
dc.rights.uriN/A
dc.titleAntioxidant and neuroprotective potential of mushroom biomass: effects on ROS production in human microglial cell line (HMC3) and alzheimer’s disease caenorhabditis elegans modelseng
dc.typeconference object
dspace.entity.typePublication
oaire.citation.endPage1
oaire.citation.startPage1
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
138559094.pdf
Tamanho:
230.42 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

CBQF - Documentos de Conferências / Conference Objects